Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
osteopeptide
- Development stage
- Preclinical
- Lead developer
- Shuguang Hospital
- Modality
- Peptides
- Administration
- Intravenous, Subcutaneous
01
Overview
Osteopeptide is the English intervention name used for a \"small bone peptide\" preparation in a prospective randomized controlled trial sponsored by Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine for early knee osteoarthritis. The public registry identifies the intervention only as osteopeptides and does not disclose a defined peptide sequence, source material, composition, manufacturer, dosage form, route, or molecular target; it therefore should not be conflated with separately named products such as compound osteopeptide injection. ([chictr.org.cn](https://www.chictr.org.cn/showproj.html?proj=42978))
- Brand names
- 古克
- Other names
- small bone peptide
02
Targets
BMP (Bone morphogenetic protein family)
Beyond the preview
Go deeper on osteopeptide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on osteopeptide.